Join Kathleen Hanlon of Infinity Pharmaceuticals for a case study presentation detailing how the TrialNetworks platform enabled Infinity to engage and challenge sites to improve enrollment in a Phase 2 global oncology trial. A Q&A session with attendees of the live session follows the prepared remarks.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…